Morgan Stanley’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.96M | Buy |
|
|||||
|
2025
Q1 | $1.36M | Sell |
|
|||||
|
2024
Q4 | $1.9M | Buy |
|
|||||
|
2024
Q3 | $1.64M | Buy |
|
|||||
|
2024
Q2 | $1.22M | Sell |
|
|||||
|
2024
Q1 | $1.63M | Sell |
|
|||||
|
2023
Q4 | $2.49M | Buy |
|
|||||
|
2023
Q3 | $795K | Sell |
|
|||||
|
2023
Q2 | $1.61M | Sell |
|
|||||
|
2023
Q1 | $1.6M | Buy |
|
|||||
|
2022
Q4 | $2.11M | Sell |
|
|||||
|
2022
Q3 | $2.83M | Buy |
|
|||||
|
2022
Q2 | $2.79M | Sell |
|
|||||
|
2022
Q1 | $3.1M | Sell |
|
|||||
|
2021
Q4 | $5.75M | Buy |
|
|||||
|
2021
Q3 | $15.5M | Sell |
|
|||||
|
2021
Q2 | $17M | Buy |
|
|||||
|
2021
Q1 | $3.6M | Sell |
|
|||||
|
2020
Q4 | $4.45M | Buy |
|